The Current State of Hybrid Coronary Revascularization

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Interventional Cardiology

Background:

• Hybrid coronary revascularization (HCR) integrates minimally invasive surgery and percutaneous coronary intervention (PCI) for multivessel coronary artery disease.
• Widespread adoption of HCR remains limited despite its established use.
• Comparative analysis of HCR against traditional coronary artery bypass graft (CABG) surgery and multivessel PCI is crucial.

Purpose of the Study:

• To comparatively assess Hybrid coronary revascularization (HCR) against traditional coronary artery bypass graft (CABG) surgery and multivessel percutaneous coronary intervention (PCI).
• To evaluate the efficacy, safety, and resource utilization of HCR in treating multivessel coronary artery disease.

Main Methods:

• Review of existing studies comparing HCR with CABG and multivessel PCI.
• Analysis of data on resource utilization, short-term morbidity, and mid- to long-term survival.
• Assessment of periprocedural morbidity and the need for repeat revascularization.

Main Results:

• HCR demonstrates comparable mid- and long-term survival to traditional CABG.
• HCR may offer advantages in resource utilization and short-term morbidity compared to CABG.
• HCR shows similar periprocedural morbidity to PCI but potentially reduces repeat revascularization through surgical arterial grafts.

Conclusions:

• HCR presents a viable alternative for multivessel coronary artery disease, balancing benefits of surgical and interventional approaches.
• Further large-scale randomized trials are needed to solidify HCR's position in clinical practice.
• HCR may optimize treatment strategies by combining the durability of arterial grafts with the precision of PCI.